Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (8)

2024

  1. Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile

    Open Forum Infectious Diseases, Vol. 11, Núm. 4

2023

  1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

2022

  1. Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19

    Chest, Vol. 162, Núm. 5, pp. 1006-1016

  2. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

    Journal of Pathology, Vol. 258, Núm. 4, pp. 426-436

2021

  1. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5

2020

  1. Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis

    Modern Pathology, Vol. 33, Núm. 8, pp. 1458-1465

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  2. CD137 (4-1BB) signalosome: Complexity is a matter of TRAFs

    Frontiers in Immunology, Vol. 9, Núm. NOV